15 November 2026

What Third-Party Testing Reveals About Peptide Purity

Presented by @peptidefieldnotes

Peptides are short chains of amino acids that serve as building blocks for a wide range of biological functions. In research settings, their purity and identity are critical because even a small impurity can alter a study's outcome or lead to misleading results. This is where third-party testing comes in. It is an independent verification process that checks whether a peptide product matches what the label claims, both in terms of chemical composition and how much of it is actually the correct peptide.

Third-party testing is not the same as in-house quality control. When a manufacturer tests its own products, there is an inherent conflict of interest. An independent lab, with no stake in the batch, provides an unbiased analysis. For researchers who rely on consistent, reproducible results, this distinction matters a great deal. The main techniques used in third-party testing are HPLC analysis and mass spectrometry. These methods can reveal a great deal about what is really in a vial.

What HPLC Analysis Tells You

High-performance liquid chromatography (HPLC) is a core method for measuring purity. In simple terms, it pumps a liquid sample through a column packed with a solid material. Different compounds in the sample travel through the column at different speeds, so they separate out as they exit. The instrument records a chromatogram, a graph with peaks. Each peak corresponds to a different compound. The area under the main peak relative to all other peaks gives a purity percentage. A purity of 98% means that 98% of the material in that sample is the correct peptide and 2% is something else, such as truncated sequences, oxidation byproducts, or leftover synthesis reagents.

HPLC also reveals the retention time of the main peak. That time is compared against a reference standard. If the retention time matches, it is a strong indication that the peptide is the one you ordered. If it shifts, the sample may contain a closely related but incorrect peptide, or the column conditions were not properly controlled. A third-party HPLC report from an accredited lab will state the method used, the column type, the mobile phase composition, the gradient profile, and the detection wavelength. Without these details, the report is less useful, because different methods can give different purity results for the same sample.

What Third-Party Testing Reveals About Peptide Purity

Mass Spectrometry Confirms Identity

While HPLC tells you how much of your sample is the target peptide, mass spectrometry (MS) answers a different question: is the peptide exactly the one you think it is? The technique measures the mass-to-charge ratio of the peptide's molecular ions. Every peptide has a unique molecular weight based on its amino acid sequence. Mass spectrometry can confirm that the observed mass matches the theoretical mass within a very tight tolerance, usually less than a few tenths of a Dalton. If the observed mass is off, the peptide is not the intended sequence. Common issues include a missing amino acid, an extra amino acid, or a modification such as oxidation or deamidation.

Mass spectrometry is often coupled with HPLC, a combination known as LC-MS. This gives both the purity and the identity confirmation in one run. For research peptides, especially those used in sensitive experiments, an LC-MS report from a third-party lab is the gold standard. It provides a single document that covers both parameters. Some labs also provide a UV trace at multiple wavelengths, which can reveal impurities that absorb at different wavelengths than the main peptide. For example, a peptide that contains a tryptophan residue will absorb strongly at 280 nm, while a non-aromatic impurity might only show at 214 nm. Comparing traces at both wavelengths gives a fuller picture of purity.

What a Certificate of Analysis Should Include

A certificate of analysis (COA) from a third-party lab is the formal document that summarizes the testing results. A thorough COA includes the following: the date of testing, the batch number, the test methods used (for example, HPLC, MS), the purity percentage, the observed molecular weight, the retention time, and the signature or stamp of the responsible analyst. Some COAs also include a copy of the chromatogram and the mass spectrum. These visual records allow you to inspect the data yourself. Look for a single clean peak in the HPLC trace and a single strong mass signal that matches the expected value. Multiple peaks or a broad mass signal are red flags.

It is also important to check that the COA refers to the same batch number that is on your vial. Third-party testing is done on a sample from a specific batch, not on the entire production run. If the batch numbers do not match, the report is not relevant to your material. Some suppliers provide a COA from their own in-house lab. While this is better than nothing, an independent third-party COA carries more weight because of the lack of bias. For critical applications, many researchers insist on seeing a third-party COA before using a peptide in an experiment.

What Third-Party Testing Cannot Tell You

No test is perfect. HPLC and mass spectrometry are powerful, but they have limitations. For example, they may not detect very low levels of certain impurities, such as residual solvents or metal ions, unless specific methods are used. A standard HPLC run might not pick up a small amount of a peptide that has the same retention time as the main product. This is called co-elution. Mass spectrometry can sometimes miss a closely related sequence if it has a very similar mass, though high-resolution instruments minimize this risk. Also, third-party testing does not assess biological activity. A peptide can be pure and correctly identified but still fail to perform in an assay because of aggregation, incorrect folding, or other physical properties. For those aspects, additional tests such as circular dichroism or bioassays are needed.

What Third-Party Testing Reveals About Peptide Purity

Another limitation is sampling. The third-party lab tests only a small portion of the batch. If the batch is not homogeneous, the test result may not represent the whole batch. Reputable manufacturers take steps to ensure homogeneity, but it is something to keep in mind. Finally, a COA is a snapshot in time. Peptides can degrade over time, especially if stored improperly. A purity of 99% at the time of testing does not guarantee that same purity six months later. That is why storage conditions and expiration dates matter.

How to Interpret Third-Party Data

When you receive a third-party report, start with the purity percentage. For research-grade peptides, anything above 95% is generally acceptable, but many labs aim for 98% or higher. The exact threshold depends on the application. For structural biology or clinical research, higher purity is often required. For screening or early-stage work, 95% may be sufficient. Next, check the identity confirmation. The mass spectrum should show a clear peak at the expected mass. If the mass is off by more than a few Daltons, the peptide is likely wrong. Also look at the chromatogram. A single symmetric peak is ideal. A fronting or tailing peak can indicate impurities that are not fully resolved. Shoulders on the main peak are a sign of closely related impurities.

Compare the retention time to any reference standard if one is available. The retention time should match within a reasonable tolerance, typically 1-2%. If the retention time is very different, the peptide may have a different sequence or a modification that changes its hydrophobicity. It is also wise to check the column temperature, gradient, and mobile phase listed on the report. If these conditions are not consistent with standard methods for that peptide, the result may be less reliable. Many third-party labs provide method details in a separate document or as a footnote on the COA.

Why This Matters for Research

Using high-purity, correctly identified peptides is essential for reproducible science. A 2015 study in the Journal of Peptide Science found that nearly 30% of commercially available peptides had a purity below 95%, and many had the wrong sequence. While that study is now several years old, the issue persists. Relying on a supplier's own claims without independent verification is a risk. Third-party testing is the most direct way to close that gap. It gives researchers confidence that the material in their hands matches the specification on the paper. For labs that work with quality documented research compounds, a third-party COA is not a luxury but a standard part of the procurement process. It ensures that the data generated from those compounds can be trusted by the entire research community.

What Third-Party Testing Reveals About Peptide Purity

When you purchase peptides from a supplier that provides third-party testing results, you are paying for peace of mind. The cost of a failed experiment due to impure material is far greater than the premium for tested peptides. This is especially true when the research involves expensive reagents, long experiments, or clinical implications. By choosing third-party tested peptides, you reduce one variable in an already complex system. You also make it easier to share your results with collaborators, because the purity data is documented and verifiable.

For researchers who work with quality documented research compounds, the choice is clear. Third-party testing reveals what is actually in the vial, not just what the label says. It protects the integrity of the work and the reputation of the lab. In a field where small differences can change an outcome, that level of assurance is invaluable.